ATNM 8-K 2026-10-15

Actinium Pharmaceuticals, Inc. (ATNM) 8-K dated 2026-10-15 — accession 0001213900-26-109884. This URL is the filing, not the ATNM hub.

Actinium Pharmaceuticals, Inc. (ATNM) is a biotechnology company listed on US.

Actinium Pharmaceuticals, Inc. filed a 8-K on 2026-10-15. Accession 0001213900-26-109884.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ATNM revenue for 2025-12-31 was $90.0K. Net income was -$33.9M. Revenue was up 11.1% from 2023-12-31 to 2025-12-31. ATNM currently screens at market cap $33.9M.

Not investment advice. The ATNM SEC hub lists recent forms. The stock page is the research view.